Effectivity of Saffron Extract (Saffr'Activ) on Treatment for Children and Adolescents with Attention Deficit/Hyperactivity Disorder (ADHD): A Clinical Effectivity Study.

Hilario Blasco-Fontecilla, Esther Moyano-Ramírez, Olga Méndez-González, María Rodrigo-Yanguas, Marina Martin-Moratinos, Marcos Bella-Fernández

Journal: Nutrients 2022;14(19):4046

PMID: 36235697

Abstract

Attention Deficit/Hyperactivity Disorder is the most prevalent neurodevelopmental disorder worldwide. Choice treatment includes psychostimulants, but parents tend to be reluctant to administer them due to side effects, and alternatives are needed. Saffron extract is a natural stimulant that has been proven safe and effective for treating a variety of mental disorders. This study compares the efficacy of saffron and the usual treatment with methylphenidate, using objective and pen-and-paper tests. We performed a non-randomized clinical trial with two groups, methylphenidate ( = 27) and saffron ( = 36), in children and adolescents aged 7 to 17. Results show that the efficacy of saffron is comparable to that of methylphenidate. Saffron is more effective for treating hyperactivity symptoms, while methylphenidate is more effective for inattention symptoms.

Address: Hospital Universitario Puerta de Hierro Majadahonda, 28222 Majadahonda, Spain.; Faculty of Medicine, Universidad Autónoma de Madrid, 28029 Madrid, Spain.; CIBERSAM (Centro de Investigación en Salud Mental), Carlos III Institute of Health, 28029 Madrid, Spain.; ITA Mental Health, 28043 Madrid, Spain.; Faculty of Psychology, Universidad Autónoma de Madrid, 28049 Madrid, Spain.; Department of Psychology, Universidad Pontificia de Comillas, 28049 Madrid, Spain.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.